CoChat

Patented inhibitors of p53–Mdm2 interaction (2006 – 2008)

Weber, Lutz · 2010 · Expert Opinion on Therapeutic Patents
Cited by 44

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

IMPORTANCE OF THE FIELD: Induction of apoptosis by reactivation of p53 in cancer cells is an emerging therapeutic concept for the treatment of cancer. The discovery and design of novel small molecules that block the p53-Mdm2 protein interaction, thereby activating p53, has provided interesting drug candidates that have currently entered clinical trials or are at the preclinical development stage. AREAS COVERED IN THIS REVIEW: A selection of the interesting patents focusing on small molecule inhibitors of the p53-Mdm2 interaction, recorded from 2006 until 2009, is presented together with a review of the related structural chemistry space. WHAT THE READER WILL GAIN: Readers will rapidly gain an overview of the majority of patented scaffolds of small molecule inhibitors of the p53-Mdm2 protein-protein interaction and learn about current limitations and properties of these compounds. TAKE HOME MESSAGE: The discovery p53-Mdm2 protein-protein interaction inhibitors have delivered new potential options for a targeted cancer therapy with drug-like, non-toxic small molecules. If successful, this approach could gain considerably more attention in the pharmaceutical industry by targeting a variety of validated intracellular protein-protein interactions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1517/13543770903514129

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 44

Metadata

Authors
Weber, L.
Venue
Expert Opinion on Therapeutic Patents
Published
2010-01-25
Volume
20
Issue
2
Pages
179-191
ISSN
  • 1354-3776 (ISSN-L)
  • 1744-7674
OpenAlex
W2113146796
Cited by
44
References
3
FWCI
3.28
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Patented inhibitors of p53–Mdm2 interaction (2006 – 2008). https://app.cochat.ai/papers/10.1517/13543770903514129
The paper
Weber, L. (2010). Patented inhibitors of p53–Mdm2 interaction (2006 – 2008). Expert Opinion on Therapeutic Patents. https://doi.org/10.1517/13543770903514129

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.